| Results summary | View all lists in GO:BiolProc | View all genes in C05A.profile.u50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.72-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 207187_AT | JAK3 | D | P | S | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | ||||||||
| 213492_AT | COL2A1 | T | D | collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) | |||||||||
| 202912_AT | ADM | G | D | X | E | C | S | adrenomedullin | |||||
| 201791_S_AT | DHCR7 | G | D | E | 7-dehydrocholesterol reductase | ||||||||
| 217270_S_AT | DYRK1B | D | P | R | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | ||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
| 204684_AT | NPTX1 | T | D | C | neuronal pentraxin I | ||||||||
| 215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 221680_S_AT | ETV7 | D | R | ets variant gene 7 (TEL2 oncogene) | |||||||||
| 206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||